Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026708 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026712 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026706 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:25
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026724 Size: 5 KB 网页链接查看全文
Adial(ADIL)04-02 04:05
$Adial(ADIL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-028701 Act: 34 Size: 6 MB 网页链接查看全文
Adial(ADIL)03-15 05:15
$Adial(ADIL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-022663 Act: 33 Size: 13 KB 网页链接查看全文
智通财经APP获悉,6月22日(周二),生物制药公司Adial Pharmaceuticals(ADIL.US)股价走高,截至北京时间22:26,该股涨超15%,报3.318美元。此前有分析指出,欧洲药品管理局(EMA)或将批准其治疗酒精使用障碍药物,这有望成为刺激该股股价... 网页链接
生物制药公司Adial Pharmaceuticals(ADIL.O)涨超19%,此前有报道称,EMA将批准其酒精使用障碍药物。 网页链接
智通财经APP获悉,6月22日(周二)美股开盘,三大指数齐涨,道琼斯指数涨0.03%,报33886.28点;标普500指数涨0.05%,报4226.78点;纳斯达克综合指数涨0.03%,报14145.52点。 个股消息 生物制药公司Adial Pharmaceuticals(ADIL.US)涨23.52%,... 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-19-026188 Act: 34 Size: 175 KB 网页链接
$Adial制药(ADIL)$ 内部交易: 2019-12-12,Chief Medical Officer,Johnson Bankole A. ,卖出,150000普通股, $1.00
$Adial制药(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-19-026186 Size: 12 KB 网页链接
$Adial制药(ADIL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-19-023298 Act: 34 Size: 3 MB 网页链接
$Adial制药(ADIL)$ 8-K - Current report Filed: 2019-10-04 AccNo: 0001213900-19-019784 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Adial制药(ADIL)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-09-13 AccNo: 0001213900-19-018002 Size: 154 KB 网页链接
$Adial制药(ADIL)$ 8-K - Current report Filed: 2019-08-20 AccNo: 0001213900-19-016383 Size: 29 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Adial制药(ADIL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001213900-19-015413 Size: 3 MB 网页链接
$Adial制药(ADIL)$ 8-K - Current report Filed: 2019-07-08 AccNo: 0001213900-19-012204 Size: 115 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Adial制药(ADIL)$ DEF 14A - Other definitive proxy statements Filed: 2019-07-08 AccNo: 0001213900-19-012205 Size: 3 MB 网页链接